Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ESPR | Common Stock | Award | $0 | +26.7K | +53.4% | $0.00 | 76.7K | Oct 29, 2021 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
holding | ESPR | Stock Option (right to buy) | 37.9K | Oct 29, 2021 | Common Stock | 37.9K | $8.94 | Direct | F1 |
Id | Content |
---|---|
F1 | The awards will vest as follows: 50% shall vest upon CVOT public presentation of results; and 50% shall vest upon obtaining approval for cardiovascular risk reduction into the U.S. label. |